Weilan Ye
16Patents
4h-index
30Co-inventors
56Inventor score
Filing activity: Apr 9, 1998 → Nov 11, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6277820A | Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells | Chemistry; Metallurgy | 22 | Expired |
| US7973138B2 | Antibodies | Chemistry; Metallurgy | 14 | Active |
| US8350010B2 | Anti-alpha5/beta1 antibody | Chemistry; Metallurgy | 10 | Active |
| US8962275B2 | Anti-α5β1 antibodies and uses thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US8404811B2 | Humanized anti-EGFL7 antibodies and methods using same | Chemistry; Metallurgy | 4 | Active |
| US7135334B2 | PRO20044 nucleic acids | Chemistry; Metallurgy | 3 | Expired |
| US8398976B2 | Antibodies to EGFL7 and methods for their use | Chemistry; Metallurgy | 2 | Active |
| US9522954B2 | Anti-LRP5 antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US8574576B2 | Humanized anti-EGFL7 antibodies and methods using same | Chemistry; Metallurgy | 1 | Active |
| US8124740B2 | Anti- α5 β1 antibodies and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US8840887B2 | Antibodies | Chemistry; Metallurgy | 1 | Active |
| US9284376B2 | Antibodies | Chemistry; Metallurgy | 0 | Active |
| US9200072B2 | Anti-LRP5 antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US8790646B2 | Compositions and methods for modulating vascular development | Human Necessities | 0 | Active |
| US10035854B2 | Method of treating retinopathy with an anti-LRP5 antibody | Chemistry; Metallurgy | 0 | Active |
| US9549971B2 | Methods for inhibiting angiogenesis using EGFL8 antagonists | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.